Nathan J. Dowden, Chief Operating Officer at Entrada Therapeutics, Inc. (TRDA), sold 8,851 shares at $18.29 ($164K) on 2022-10-21, disclosed to the SEC on 2022-10-24.
Open-market sale of $164k TRDA by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.07 | 905 | $16K | 10.0% |
| 2 | $18.29 | 2,771 | $51K | 30.9% |
| 3 | $18.29 | 2,771 | $51K | 30.9% |
| 4 | $18.88 | 1,102 | $21K | 12.7% |
| 5 | $19.66 | 1,302 | $26K | 15.6% |
| Total | $18.54 avg | 8,851 |
| $164K |
| 100% |
| Filing → |
| TRDA | SELL | 2024-09-30 | $14K | — | Filing → |
| TRDA | SELL | 2024-09-10 | $35K | — | Filing → |
| TRDA | SELL | 2024-08-20 | $873K | — | Filing → |